Looks like you clickedhttps://www.europeanpharmaceuticalreview.com/news/177098/ema-accepts-myelofibrosis-momelotinib-marketing-application/#:~:text=GSK%20has%20announced%20that%20the,anaemia%2C%20symptoms%2C%20and%20splenomegaly
If you do not want to visit that page, you can close this browser tab.
